BG25518A3 - Метод за получаване на ксантинови производни - Google Patents

Метод за получаване на ксантинови производни

Info

Publication number
BG25518A3
BG25518A3 BG032887A BG3288775A BG25518A3 BG 25518 A3 BG25518 A3 BG 25518A3 BG 032887 A BG032887 A BG 032887A BG 3288775 A BG3288775 A BG 3288775A BG 25518 A3 BG25518 A3 BG 25518A3
Authority
BG
Bulgaria
Prior art keywords
obtaining
xanthine derivatives
xanthine
derivatives
obtaining xanthine
Prior art date
Application number
BG032887A
Other languages
Bulgarian (bg)
English (en)
Inventor
Wilhelm Ronz
Richard Reichl
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG25518A3 publication Critical patent/BG25518A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG032887A 1974-12-21 1975-12-19 Метод за получаване на ксантинови производни BG25518A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (1)

Publication Number Publication Date
BG25518A3 true BG25518A3 (bg) 1978-10-10

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
BG032887A BG25518A3 (bg) 1974-12-21 1975-12-19 Метод за получаване на ксантинови производни

Country Status (31)

Country Link
US (1) US3998953A (en, 2012)
JP (1) JPS5188995A (en, 2012)
AT (1) AT341540B (en, 2012)
AU (1) AU501889B2 (en, 2012)
BE (1) BE836898A (en, 2012)
BG (1) BG25518A3 (en, 2012)
CA (1) CA1036159A (en, 2012)
CH (1) CH628346A5 (en, 2012)
CS (1) CS191289B2 (en, 2012)
DD (1) DD124984A5 (en, 2012)
DE (1) DE2460929A1 (en, 2012)
DK (1) DK137677C (en, 2012)
ES (2) ES443738A1 (en, 2012)
FI (1) FI62089C (en, 2012)
FR (1) FR2294706A1 (en, 2012)
GB (1) GB1517710A (en, 2012)
GR (1) GR59204B (en, 2012)
HU (1) HU174673B (en, 2012)
IE (1) IE43208B1 (en, 2012)
IL (1) IL48697A (en, 2012)
LU (1) LU73972A1 (en, 2012)
NL (1) NL7514837A (en, 2012)
NO (1) NO144928C (en, 2012)
NZ (1) NZ179599A (en, 2012)
PH (1) PH11810A (en, 2012)
PL (1) PL99165B1 (en, 2012)
RO (1) RO68381A (en, 2012)
SE (1) SE420493B (en, 2012)
SU (1) SU603340A3 (en, 2012)
YU (1) YU39004B (en, 2012)
ZA (1) ZA757865B (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (en, 2012) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (en, 2012) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
AU8754775A (en) 1977-06-23
FR2294706A1 (fr) 1976-07-16
ES443738A1 (es) 1977-04-16
HU174673B (hu) 1980-03-28
IL48697A0 (en) 1976-02-29
FI62089C (fi) 1982-11-10
DK571875A (da) 1976-06-22
FI753543A7 (en, 2012) 1976-06-22
RO68381A (ro) 1982-02-26
ZA757865B (en) 1977-08-31
YU39004B (en) 1983-12-31
US3998953A (en) 1976-12-21
IL48697A (en) 1979-07-25
DK137677B (da) 1978-04-17
CH628346A5 (de) 1982-02-26
BE836898A (fr) 1976-06-21
IE43208B1 (en) 1981-01-14
PL99165B1 (pl) 1978-06-30
SE420493B (sv) 1981-10-12
GB1517710A (en) 1978-07-12
PH11810A (en) 1978-07-10
FR2294706B1 (en, 2012) 1978-12-01
ES451457A1 (es) 1977-10-01
FI62089B (fi) 1982-07-30
LU73972A1 (en, 2012) 1977-02-15
NO144928C (no) 1981-12-09
CS191289B2 (en) 1979-06-29
YU323475A (en) 1982-08-31
NL7514837A (nl) 1976-06-23
NO144928B (no) 1981-08-31
JPS5188995A (en, 2012) 1976-08-04
AU501889B2 (en) 1979-07-05
AT341540B (de) 1978-02-10
ATA904575A (de) 1977-06-15
SU603340A3 (ru) 1978-04-15
NO754317L (en, 2012) 1976-06-22
DE2460929A1 (de) 1976-06-24
IE43208L (en) 1976-06-21
GR59204B (en) 1977-11-26
SE7514477L (sv) 1976-06-22
DD124984A5 (en, 2012) 1977-03-23
DE2460929C2 (en, 2012) 1987-12-17
NZ179599A (en) 1978-03-06
DK137677C (da) 1978-09-25
CA1036159A (en) 1978-08-08

Similar Documents

Publication Publication Date Title
BG25094A3 (bg) Метод за получаване на субституирани пурини
BG27744A3 (bg) Метод за получаване на ханазолинови производни
BG23216A3 (bg) Метод за получаване на бензимидазоли
BG27380A3 (bg) Метод за получаване на еритромициламинови производни
BG26516A3 (bg) Метод за получаване на n-фосфонометил-глицин
BG26515A3 (bg) Метод за получаване на ациламинопроизводни
BG26518A3 (bg) Метод за получаване на производни на фенил-алкан
BG26201A3 (bg) Метод за получаване на 7-бета-амино-3-цефем-3-ол- 4-карбонови киселини
BG25517A3 (bg) Метод за получаване на имидазолови производни
BG25082A3 (bg) Метод за получаване на 1-ароил-2-ариламино-2-имидазолови производни
BG27091A3 (bg) Метод за получаване на цефамови производни
BG26374A3 (bg) Метод за получаване на бензимидазолови производни
BG24799A3 (bg) Метод за получаване на бензоилуреидо-дифенилетери
BG26400A3 (bg) Метод за получаване на производни на диаминоциклитоли
BG23901A3 (bg) Метод за получаване на пиридобензодиазепинони
BG25518A3 (bg) Метод за получаване на ксантинови производни
BG27230A3 (bg) Метод за получаване на субституирани индоленини
BG26368A3 (bg) Метод за получаване на аминокиселинни производни
BG24801A3 (bg) Метод за получаване наl-пироглутамилl-пролинамид
BG26377A4 (bg) Метод за получаване на бензодиазепинови производни
BG26527A3 (bg) Метод за получаване на 2-ариламино-2-имидазолинови производни
BG27361A3 (bg) Метод за получаване на заместени карбамидни производни
BG27227A3 (bg) Метод за получаване на 11-дозокси-15-заместени омега- пентанорпростагландини
BG27089A3 (bg) Метод за получаване на индохинолизидинови производни
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat